Market Cap ₹344 Cr.
Stock P/E 22.5
P/B 2.4
Current Price ₹166.2
Book Value ₹ 69.1
Face Value 10
52W High ₹247.9
Dividend Yield 0%
52W Low ₹ 124.1
Essen Speciality Films Ltd is a dynamic and innovative company specializing in the production and distribution of high-quality specialty films. With a strong focus on meeting customer needs, the company offers a diverse range of films designed for various industries and applications. From flexible packaging solutions to laminating films, barrier films, and specialty coatings, Essen Speciality Films provides cutting-edge products that cater to the unique requirements of its clients. Committed to excellence, the company leverages advanced manufacturing techniques and state-of-the-art equipment to ensure superior product quality and consistency. Their dedicated team of professionals combines expertise, creativity, and customer-centric approach to deliver customized solutions that exceed expectations. By constantly investing in research and development, Essen Speciality Films stays at the forefront of technological advancements and strives to provide innovative solutions to its customers. With a strong presence in both domestic and international markets, Essen Speciality Films has earned a reputation for reliability, integrity, and customer satisfaction.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 28 | 21 | 33 | 36 | 31 | 34 | 38 | 40 |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| Total Income | 28 | 22 | 34 | 37 | 31 | 34 | 38 | 41 |
| Total Expenditure | 25 | 19 | 26 | 29 | 25 | 27 | 31 | 37 |
| Operating Profit | 4 | 3 | 7 | 8 | 7 | 8 | 8 | 4 |
| Interest | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 1 | 6 | 6 | 5 | 5 | 6 | 3 |
| Provision for Tax | 0 | 0 | 2 | -1 | 1 | 1 | 1 | 1 |
| Profit After Tax | 2 | 1 | 4 | 7 | 4 | 4 | 5 | 2 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 2 | 1 | 4 | 7 | 4 | 4 | 5 | 2 |
| Adjusted Earnings Per Share | 1.2 | 0.5 | 2.6 | 4.6 | 2.3 | 2 | 2.2 | 0.9 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|
| Net Sales | 73 | 96 | 117 | 119 | 143 |
| Other Income | 1 | 1 | 1 | 2 | 1 |
| Total Income | 73 | 97 | 119 | 120 | 144 |
| Total Expenditure | 58 | 77 | 105 | 100 | 120 |
| Operating Profit | 15 | 20 | 14 | 21 | 27 |
| Interest | 1 | 1 | 3 | 3 | 1 |
| Depreciation | 3 | 6 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 11 | 12 | 7 | 14 | 19 |
| Provision for Tax | 3 | 3 | 2 | 1 | 4 |
| Profit After Tax | 8 | 9 | 5 | 13 | 15 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 8 | 9 | 5 | 13 | 15 |
| Adjusted Earnings Per Share | 5 | 5.7 | 3.2 | 8.4 | 7.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 2% | 18% | 0% | 0% |
| Operating Profit CAGR | 50% | 12% | 0% | 0% |
| PAT CAGR | 160% | 18% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 17% | 13% | 13% | 13% |
| ROCE Average | 18% | 16% | 16% | 16% |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Shareholder's Funds | 60 | 67 | 72 | 86 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 4 | 3 |
| Other Non-Current Liabilities | 6 | 5 | 5 | 2 |
| Total Current Liabilities | 10 | 32 | 38 | 19 |
| Total Liabilities | 76 | 104 | 119 | 110 |
| Fixed Assets | 41 | 41 | 44 | 43 |
| Other Non-Current Assets | 1 | 1 | 1 | 2 |
| Total Current Assets | 33 | 62 | 73 | 65 |
| Total Assets | 76 | 104 | 119 | 110 |
| #(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 2 | 2 | 0 |
| Cash Flow from Operating Activities | 7 | 8 | -7 | 25 |
| Cash Flow from Investing Activities | -2 | -8 | -3 | -3 |
| Cash Flow from Financing Activities | -6 | 8 | 8 | -22 |
| Net Cash Inflow / Outflow | -0 | 8 | -2 | 0 |
| Closing Cash & Cash Equivalent | 2 | 11 | 0 | 1 |
| # | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.97 | 5.71 | 3.23 | 8.36 |
| CEPS(Rs) | 7.15 | 9.62 | 5.7 | 10.7 |
| DPS(Rs) | 25 | 20 | 0 | 0 |
| Book NAV/Share(Rs) | 37.46 | 41.92 | 45.15 | 53.51 |
| Core EBITDA Margin(%) | 19.9 | 19.4 | 10.66 | 15.86 |
| EBIT Margin(%) | 15.91 | 13.95 | 8.27 | 14.28 |
| Pre Tax Margin(%) | 14.91 | 12.9 | 5.85 | 12.07 |
| PAT Margin (%) | 10.91 | 9.54 | 4.4 | 11.27 |
| Cash Profit Margin (%) | 15.71 | 16.07 | 7.76 | 14.43 |
| ROA(%) | 10.52 | 10.15 | 4.64 | 11.71 |
| ROE(%) | 13.27 | 14.39 | 7.42 | 16.94 |
| ROCE(%) | 18.01 | 18.2 | 10.76 | 17.8 |
| Receivable days | 38.37 | 41.73 | 44.52 | 48.17 |
| Inventory Days | 44.66 | 47.6 | 74.87 | 95.77 |
| Payable days | 28.44 | 58.59 | 64.99 | 72.3 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.04 | 0.06 | 0.32 | 0.15 |
| EV/Core EBITDA(x) | 0.2 | 0.3 | 2.77 | 0.83 |
| Net Sales Growth(%) | 0 | 31.42 | 22.61 | 1 |
| EBIT Growth(%) | 0 | 15.24 | -27.32 | 74.35 |
| PAT Growth(%) | 0 | 14.87 | -43.43 | 158.7 |
| EPS Growth(%) | 0 | 14.87 | -43.43 | 158.7 |
| Debt/Equity(x) | 0.07 | 0.23 | 0.36 | 0.08 |
| Current Ratio(x) | 3.33 | 1.92 | 1.91 | 3.46 |
| Quick Ratio(x) | 2.45 | 1.42 | 1.07 | 1.85 |
| Interest Cover(x) | 15.99 | 13.28 | 3.42 | 6.47 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| Promoter | 70.05 | 70.07 | 70.09 |
| FII | 2.63 | 0.79 | 0.6 |
| DII | 2.75 | 2.3 | 2.3 |
| Public | 24.57 | 26.84 | 27.02 |
| Others | 0 | 0 | 0 |
| Total | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|
| Promoter | 1.45 | 1.45 | 1.45 |
| FII | 0.05 | 0.02 | 0.01 |
| DII | 0.06 | 0.05 | 0.05 |
| Public | 0.51 | 0.56 | 0.56 |
| Others | 0 | 0 | 0 |
| Total | 2.07 | 2.07 | 2.07 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
